EGFR and non-small cell lung carcinoma: In our laboratory, the Cobas EGFR Mutation Test (Roche Diagnostics GmbH) showed more than 83% sensitivity and 100% specificity for detecting EGFR mutations in plasma cfDNA from 50 advanced NSCLC patients [36].